In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

Tambone, S., Fargnoli, M., Capizzi, R., Peris, K., Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series, <<GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA>>, 2015; (Ottobre): N/A-N/A [http://hdl.handle.net/10807/72789]

Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

Capizzi, Rodolfo;Peris, Ketty
2015

Abstract

In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.
eng
Tambone, S., Fargnoli, M., Capizzi, R., Peris, K., Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series, <>, 2015; (Ottobre): N/A-N/A [http://hdl.handle.net/10807/72789]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/72789
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact